Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

MedTech Procurement Governance & Anticorruption Enforcement: Police Arrest Deputy Minister of Health Tran Van Thuan for Bribery in Widening Probe into Viet My Medical Investment JSC Involving Cross-Border Markups of Oncology and Nuclear Medicine Systems

03/09/2026 Published by Pharma Biz

Key Development On September 2, 2026, the Investigation Police Department for Corruption, Smuggling, and Economic Crimes (C03, Ministry of Public... Read more

Tags: #Vietnam

Precision Oncology & Molecular Therapeutics: US FDA Clears Revolution Medicines’ Rasonque® (Daraxonrasib) for Metastatic Pancreatic Ductal Adenocarcinoma – Doubling Median Overall Survival to 13.2 Months with $477,600 Annual WAC Pricing

03/09/2026 Published by Pharma Biz

Key Development On August 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque® (daraxonrasib), an oral small-molecule therapeutic... Read more

Category: Uncategorized

Tags: #Global Trends

Food Safety & Digital Supplement Enforcement: Vietnam Food Administration (MOH) Issues Urgent Directive Mandating HCMC Inspection of ‘Love World Nutrition Coffee’ for Deceptive Weight-Loss Marketing – Final Report Due by September 10, 2026

03/09/2026 Published by Pharma Biz

Key Development On the afternoon of August 30, 2026, the Vietnam Food Administration (VFA) under the Ministry of Health issued... Read more

Category: Uncategorized

Tags: #Vietnam

TEVA’S TEV-408 PHASE 2A SUCCESS OPENS A NEW THERAPEUTIC PATHWAY IN CELIAC DISEASE AND STRENGTHENS ITS IMMUNOLOGY PIVOT

03/09/2026 Published by HealthBiz

Key Development Teva Pharmaceutical Industries has reported positive Phase 2a topline results for TEV-408, an investigational human monoclonal antibody targeting... Read more

Category: Uncategorized

Tags: #Global Trends

Public Health & Seasonal Immunization: US FDA Clears Pfizer and BioNTech’s Updated COMIRNATY® XFG mRNA Vaccine for the 2026–2027 Respiratory Season Targeting Circulating SARS-CoV-2 Variants

31/08/2026 Published by Pharma Biz

Key Development On August 28, 2026, the U.S. Food and Drug Administration (FDA) officially approved the supplemental Biologics License Application... Read more

Category: Uncategorized

Tags: #Global Trends

Antiviral Therapeutics & Formulation Innovation: US FDA Approves Gilead’s Bixlenvo® (Bictegravir / Lenacapavir) as First and Smallest Once-Daily Single-Tablet Regimen for Virologically Suppressed HIV Adults Transitioning from Multi-Pill Regimens

31/08/2026 Published by Pharma Biz

Key Development On August 28, 2026, the U.S. Food and Drug Administration (FDA) officially granted marketing approval for Bixlenvo® (bictegravir... Read more

Category: Uncategorized

Tags: #Global Trends

Precision Oncology & Next-Gen ADC Platforms: Genentech and DualityBio Enter Potential $1 Billion+ Global Alliance to Pioneer Novel Payload-Linker Platforms Overcoming Topoisomerase Inhibitor Resistance

31/08/2026 Published by Pharma Biz

Key Development On August 28, 2026, clinical-stage biotechnology innovator DualityBio entered into an exclusive global research collaboration and licensing agreement... Read more

Category: Uncategorized

Tags: #M&A

Consumer Healthcare & FMCG Mega-Merger: Kimberly-Clark Requests European Commission Clearance for $40 Billion Acquisition of Kenvue to Form $32 Billion Powerhouse with $2.1 Billion Annual Cost Synergies

31/08/2026 Published by Pharma Biz

Key Development On August 28, 2026, global personal care and consumer products enterprise Kimberly-Clark Corporation (NYSE: KMB) formally submitted a... Read more

Category: Uncategorized

Tags: #M&A